Literature DB >> 12856230

Postmalaria neurological syndrome after treatment of Plasmodium falciparum malaria in the United States.

Gerald S Falchook1, Clinton M Malone, Scott Upton, Wayne X Shandera.   

Abstract

The neuropsychiatric manifestations of postmalaria neurological syndrome (PMNS) that have been described are highly variable and include an acute confusional state or acute psychosis with >or=1 of the following symptoms: clouding of consciousness, inappropriate speech or behavior, visual hallucination, catatonia with waxy flexibility, generalized convulsion, fine postural tremor, and decreased muscle tone. This postinfectious syndrome occurs after the clearance of parasitemia and is not a manifestation of cerebral malaria. We present the first identified case of and magnetic resonance imaging findings for a patient with PMNS in the United States.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12856230     DOI: 10.1086/375269

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

1.  Genetic confirmation of quinine-resistant Plasmodium falciparum malaria followed by postmalaria neurological syndrome in a traveler from Mozambique.

Authors:  Fabrizio Palmieri; Nicola Petrosillo; Maria Grazia Paglia; Aristide Conte; Delia Goletti; Leopoldo Paolo Pucillo; Michela Menegon; Anna Sannella; Carlo Severini; Giancarlo Majori
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

2.  Acute disseminated encephalomyelitis (ADEM)--a rare complication of falciparum malaria.

Authors:  Sarangi Rachita; Mahapatra Satyasundar; Dash Mrutunjaya; Rath Birakishore
Journal:  Indian J Pediatr       Date:  2012-06-15       Impact factor: 1.967

Review 3.  Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome.

Authors:  Richard Idro; Kevin Marsh; Chandy C John; Charles R J Newton
Journal:  Pediatr Res       Date:  2010-10       Impact factor: 3.756

4.  Persistent cognitive and motor deficits after successful antimalarial treatment in murine cerebral malaria.

Authors:  Minxian Dai; Sandra E Reznik; David C Spray; Louis M Weiss; Herbert B Tanowitz; Maria Gulinello; Mahalia S Desruisseaux
Journal:  Microbes Infect       Date:  2010-08-26       Impact factor: 2.700

Review 5.  Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.

Authors:  Margaret K King; Marta Pardo; Yuyan Cheng; Kimberlee Downey; Richard S Jope; Eléonore Beurel
Journal:  Pharmacol Ther       Date:  2013-07-31       Impact factor: 12.310

6.  Steroid Pulse Therapy May Mitigate Prolonged Neurological Manifestations after Eradication of Severe Plasmodium falciparum Parasitemia.

Authors:  Chihiro Hasegawa; Akiko Inagaki; Gohei Yamada; Koji Morita; Isamu Kitamura; Koya Ariyoshi
Journal:  Intern Med       Date:  2016-11-15       Impact factor: 1.271

Review 7.  Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework.

Authors:  Yanis Tamzali; Sophie Demeret; Elie Haddad; Hélène Guillot; Eric Caumes; Stéphane Jauréguiberry
Journal:  Malar J       Date:  2018-10-26       Impact factor: 2.979

8.  Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment.

Authors:  Minxian Dai; Brandi Freeman; Henry J Shikani; Fernando Pereira Bruno; J Elias Collado; Rolando Macias; Sandra E Reznik; Peter Davies; David Conover Spray; Herbert Bernard Tanowitz; Louis Martin Weiss; Mahalia Sabrina Desruisseaux
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

9.  Hypopituitarism: A rare sequel of cerebral malaria - Presenting as delayed awakening from general anesthesia.

Authors:  Venkatesh Selvaraj
Journal:  Anesth Essays Res       Date:  2015 May-Aug

10.  Endothelin-1 Mediates Brain Microvascular Dysfunction Leading to Long-Term Cognitive Impairment in a Model of Experimental Cerebral Malaria.

Authors:  Brandi D Freeman; Yuri C Martins; Oscar B Akide-Ndunge; Fernando P Bruno; Hua Wang; Herbert B Tanowitz; David C Spray; Mahalia S Desruisseaux
Journal:  PLoS Pathog       Date:  2016-03-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.